AtriCure Inc. Sets New 1-Year High at $11.69 (ATRC)
AtriCure (NASDAQ:ATRC) set a new 52-week high during trading on Tuesday, AnalystRatingsNetwork reports. The stock traded as high as $11.69 and last traded at $11.56, with a volume of 63,412 shares. The stock had previously closed at $10.98.
AtriCure has a 52-week low of $5.90 and a 52-week high of $11.69. The stock has a 50-day moving average of $9.95 and a 200-day moving average of $9.22. The company’s market cap is $241.3 million.
AtriCure (NASDAQ:ATRC) last issued its quarterly earnings data on Thursday, August 1st. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.01. The company had revenue of $20.40 million for the quarter, compared to the consensus estimate of $19.42 million. During the same quarter in the previous year, the company posted ($0.08) earnings per share. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. Analysts expect that AtriCure will post $-0.46 EPS for the current fiscal year.
AtriCure, Inc, is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.